nVerses Capital’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
nVerses Capital's MGNX Position: Q3 2026 in Review
nVerses Capital sold out of MacroGenics (MGNX) in Q3 2026, closing a stake of 29,090 shares — an estimated $134K sold.
nVerses Capital first reported a position in MGNX in Q2 2026 and held it in 1 quarter. The position peaked at $134K in Q2 2026. 129 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.
- nVerses Capital reported no remaining MacroGenics position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 29,090 MacroGenics shares in Q3 2026, an estimated $134K.
- nVerses Capital first reported a position in MacroGenics in Q2 2026 and held it in 1 quarter.
- nVerses Capital's MacroGenics position peaked at $134K in Q2 2026.
- 129 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.